Back to Search
MICHAEL CHANCELLOR, MD
MD
Specialist
NPI: 1326010281Individual
Specialties, Licenses & Credentials
Urology Physician
Urology
Code: 208800000X
4301048056(MI)
SpecialistPrimary
Specialist
Code: 174400000X
MD041546L(PA)
Research & Publications (20)
A comparison of the efficacy of darifenacin alone vs. darifenacin plus a Behavioural Modification Programme upon the symptoms of overactive bladder.
PMID 18324952·Int J Clin Pract·2008
4-observational
A Multidisciplinary Consensus Meeting on IC/PBS: Outcome of the Consensus Meeting on Interstitial Cystitis/Painful Bladder Syndrome, February 10, 2007, Washington, DC.
PMID 17592542·Rev Urol·2007
8-other
Treatment of overactive bladder: selective use of anticholinergic agents with low drug-drug interaction potential.
PMID 17489643·Geriatrics·2007
6-review
Pharmacotherapy for neurogenic detrusor overactivity.
PMID 16715024·Am J Phys Med Rehabil·2006
6-review
Pittsburgh experience with lower urinary tract botulinum toxin A injection.
PMID 15978220·Curr Urol Rep·2005
8-other
Recent advances in the neurophysiology of stress urinary incontinence.
PMID 15764266·Scand J Urol Nephrol·2005
6-review
Nitric oxide synthase gene transfer for erectile dysfunction in a rat model.
PMID 12699487·BJU Int·2003
7-preclinical
A comparison of the effects on saliva output of oxybutynin chloride and tolterodine tartrate.
PMID 11394733·Clin Ther·2001
3-trial
Preliminary results of myoblast injection into the urethra and bladder wall: a possible method for the treatment of stress urinary incontinence and impaired detrusor contractility.
PMID 10797585·Neurourol Urodyn·2000
7-preclinical
Obesity is associated with a more severe overactive bladder disease state that is effectively treated with once-daily administration of trospium chloride extended release.
PMID 19634167·Neurourol Urodyn·2010
4-observational
Ten years single surgeon experience with botulinum toxin in the urinary tract; clinical observations and research discovery.
PMID 19572209·Int Urol Nephrol·2010
6-review
Is behavioral therapy plus antimuscarinic better than drug alone to treat overactive bladder?
PMID 19145277·Rev Urol·2008
8-other
Efficacy of solifenacin in patients previously treated with tolterodine extended release 4 mg: results of a 12-week, multicenter, open-label, flexible-dose study.
PMID 19014833·Clin Ther·2008
3-trial
Drug Insight: biological effects of botulinum toxin A in the lower urinary tract.
PMID 18461049·Nat Clin Pract Urol·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3471 5TH AVE, SUITE 801
PITTSBURGH, PA 15213 - Phone
- (412) 692-4100
Quick Facts
- NPI
- 1326010281
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile